
Sign up to save your podcasts
Or


Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts
By Hippo Education LLC.,4.7
119119 ratings
Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts

697 Listeners

497 Listeners

255 Listeners

297 Listeners

259 Listeners

3,348 Listeners

267 Listeners

1,148 Listeners

194 Listeners

515 Listeners

368 Listeners

248 Listeners

232 Listeners

313 Listeners

79 Listeners